Nav: Home

Can aspirin decrease the rate of intracranial aneurysm growth?

October 29, 2019

CHARLOTTESVILLE, VA (OCTOBER 29, 2019). Researchers conducted a database search to investigate whether aspirin can aid in the prevention of intracranial aneurysm rupture by hindering aneurysm growth. The researchers identified 146 patients harboring multiple intracranial aneurysms, five millimeters or less in diameter, that had been observed for at least five years. In this set of patients, the researchers found an association between aspirin use and a decreased rate of aneurysm growth. Growth is important in intracranial aneurysms because it increases the risk of aneurysm rupture. Detailed findings are found in the article, "Aspirin associated with decreased rate of intracranial aneurysm growth," by Mario Zanaty, M.D., and colleagues, published today in the Journal of Neurosurgery.

Background

An intracranial aneurysm is a cerebrovascular disorder in which the wall of an artery in the brain has weakened and bulges outward. The worry is that the weakened aneurysm wall might rupture, causing subarachnoid hemorrhage--bleeding in the brain.

According to the Brain Aneurysm Foundation, in the United States an estimated 6.5 million people have an unruptured intracranial artery. It is not unusual to have more than one. Many small aneurysms do not cause symptoms and are unlikely to rupture. We may only know that they exist because they are identified on imaging studies obtained for another reason.

Each year, however, approximately 30,000 people in the United States experience aneurysm rupture. A ruptured aneurysm can result in substantial disability and even death.

Aneurysms larger than 7 mm are more likely to rupture than small ones. Unfortunately, some small aneurysms grow, increasing the risks that they may rupture. It is for this reason that physicians observe small, unruptured aneurysms over time by asking patients to undergo regularly scheduled imaging examinations. When it comes to the brain, intervention carries risks as well, and most neurosurgeons would prefer not to treat a small, unruptured aneurysm unless the risk of rupture meets or exceeds the risk of intervention.

The authors of this paper note, "to date, there is no medical treatment to arrest aneurysm growth and subsequent progression to rupture." If there were, patients could feel assured that the risk of aneurysm rupture would remain steady. The authors do tell us that there has been some evidence that aspirin may reduce the risk of aneurysm rupture due to the drug's anti-inflammatory effect on the weakened aneurysm wall. Their aim in the current study was to discover whether aspirin can protect against aneurysm growth in a population of patients harboring multiple small intracranial aneurysms.

Present Study

The data collected by the researchers came from the medical records of 146 patients with multiple intracranial saccular aneurysms, who had undergone surgical or endovascular treatment by the senior author, David M. Hasan, M.D., initially for one aneurysm that had ruptured or was deemed at risk for rupture. Following treatment of this primary aneurysm, the patients still harbored a total of 229 intracranial aneurysms, all of which measured five millimeters or less. These 229 aneurysms are the focus of this paper. The patients periodically returned for follow-up appointments with Dr. Hasan, during which their remaining aneurysms were assessed for growth. Growth was defined as an increase in aneurysm size of at least one millimeter. If growth was identified, the aneurysm was treated. This occurred with 24 aneurysms.

By the end of the study period (July 2009-January 2019), each patient had been monitored for at least 5 years. None of the 229 aneurysms ruptured during the study period.

To examine what factors might lead to aneurysm growth or protect against aneurysm growth over time, the authors performed univariate and multivariate analyses on a variety of demographic and aneurysm-related information retrieved from the database. These included patient age and sex, family and patient medical history, present comorbidities, aneurysm size and location in the brain, status of the primary aneurysm (ruptured or unruptured) prior to treatment, type of procedure used to treat aneurysms, daily use of at least 81 milligrams aspirin, and use of another anticoagulant medication.

According to the univariate analysis, significant predictors of aneurysm growth included a patient's history of ruptured aneurysm, drug abuse, hypertension, and polycystic kidney disease. There was an association between both aspirin use and one type of treatment, stent-assisted coil embolization, and a lower rate of aneurysm growth. In the multivariate analysis, the independent factors associated with aneurysm growth were again patient's history of ruptured aneurysm, drug abuse, hypertension, and polycystic kidney disease. Only aspirin use proved to be associated with a significant decreased rate of aneurysm growth.

On the basis of the statistical analyses, use of aspirin appears to exert a protective effect against aneurysm growth and very likely against future rupture.

The authors point out that their findings are observational and that future, interventional studies should be conducted.

When asked about the study, Dr. Hasan said, "This study is very promising, as it outlines for the first time the potential therapeutic effect of aspirin in decreasing aneurysm growth. If proven in a larger study, this could offer the first, cheap, effective over-the-counter therapeutic agent that could halt aneurysm growth and prevent rupture. Many people around the world could benefit from this."
-end-
Zanaty M, Roa Jorge A, Nakagawa D, Chalouhi N, Allan L, Al Kasab S. Limaye K, Ishii D, Samaniego EA, Jabbour P, Torner JC, Hasan DM: Aspirin associated with decreased rate of intracranial aneurysm growth. Journal of Neurosurgery, published online, ahead of print, October 29, 2019; DOI: 10.3171/2019.6.JNS191273.

Disclosure: The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.

Drs. Zanaty, Roa, Allan, Al Kasab, Limaye, Samaniego, Torner, and Hassan are affiliated with the University of Iowa Hospitals and Clinics, Iowa City, Iowa; Dr. Nakagawa with The University of Tokyo Hospital, Tokyo, Japan; Drs. Chalouhi and Jabbour with Thomas Jefferson University Hospital, Philadelphia, Pennsylvania; and Dr. Ishii with Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.

For additional information, please contact: Ms. Jo Ann M. Eliason, Communications Manager, Journal of Neurosurgery Publishing Group, One Morton Drive, Suite 200, Charlottesville, VA 22903. Email: jaeliason@thejns.org; Phone: 434-982-1209.

For 75 years, the Journal of Neurosurgery has been recognized by neurosurgeons and other medical specialists the world over for its authoritative clinical articles, cutting-edge laboratory research papers, renowned case reports, expert technical notes, and more. Each article is rigorously peer reviewed. The Journal of Neurosurgery is published monthly by the JNS Publishing Group, the scholarly journal division of the American Association of Neurological Surgeons. Other peer-reviewed journals published by the JNS Publishing Group include Neurosurgical Focus, Neurosurgical Focus: Video, the Journal of Neurosurgery: Spine, and the Journal of Neurosurgery: Pediatrics. All five journals can be accessed at http://www.thejns.org.

Founded in 1931 as the Harvey Cushing Society, the American Association of Neurological Surgeons (AANS) is a scientific and educational association with more than 10,000 members worldwide. The AANS is dedicated to advancing the specialty of neurological surgery in order to provide the highest quality of neurosurgical care to the public. All active members of the AANS are certified by the American Board of Neurological Surgery, the Royal College of Physicians and Surgeons (Neurosurgery) of Canada or the Mexican Council of Neurological Surgery, AC. Neurological surgery is the medical specialty concerned with the prevention, diagnosis, treatment, and rehabilitation of disorders that affect the entire nervous system including the brain, spinal column, spinal cord, and peripheral nerves. For more information, visit http://www.AANS.org.

Journal of Neurosurgery Publishing Group

Related Aspirin Articles:

Migraine headaches? Consider aspirin for treatment and prevention
Evidence from 13 randomized trials of the treatment of migraine in 4,222 patients and tens of thousands of patients in prevention of recurrent attacks supports the use of high dose aspirin from 900 to 1,300 milligrams to treat acute migraine as well as low dose daily aspirin from 81 to 325 milligrams to prevent recurrent attacks.
Aspirin use after biliary tract cancer diagnosis
Researchers in this observational study examined if aspirin use after a diagnosis of a biliary tract cancer, which includes gallbladder cancer, was associated with reduced risk of death among nearly 3,000 patients.
Aspirin may prevent air pollution harms
A new study is the first to report evidence that nonsteroidal anti-inflammatory drugs (NSAIDs) like aspirin may lessen the adverse effects of air pollution exposure on lung function.
Aspirin should not be recommended for healthy people over 70
Low-dose aspirin does not prolong disability-free survival of healthy people over 70, even in those at the highest risk of cardiovascular disease.
Frequent use of aspirin can lead to increased bleeding
A new study published today in the Journal of the American Medical Association (JAMA) has found that taking aspirin on a regular basis to prevent heart attacks and strokes, can lead to an increase risk of almost 50 percent in major bleeding episodes.
Analyzing aspirin use in patients without cardiovascular disease
This study analyzed combined results from 13 randomized clinical trials with more than 164,000 participants to assess aspirin use with the prevention of cardiovascular events and bleeding in people without cardiovascular disease.
How baby aspirin saves lives (video)
Low-dose 'baby' aspirin is rarely given to children anymore. Instead, people at risk of a heart attack may take a daily aspirin to decrease their risk.
Aspirin found not to prolong healthy aging
Taking a low-dose aspirin daily does not prolong healthy living in older adults, according to findings from the ASPirin in Reducing Events in the Elderly (ASPREE) trial published online Sept.
Can aspirin treat Alzheimer's?
regimen of low-dose aspirin potentially may reduce plaques in the brain, which will reduce Alzheimer's disease pathology and protect memory, according to neurological researchers at Rush University Medical Center, who published the results of their study today in the July issue of The Journal of Neuroscience.
Treating Alzheimer's with aspirin
A low-dose aspirin regimen may represent a new avenue for reducing Alzheimer's disease pathology, according to new research in a mouse model of the disease published in JNeurosci.
More Aspirin News and Aspirin Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

Accessing Better Health
Essential health care is a right, not a privilege ... or is it? This hour, TED speakers explore how we can give everyone access to a healthier way of life, despite who you are or where you live. Guests include physician Raj Panjabi, former NYC health commissioner Mary Bassett, researcher Michael Hendryx, and neuroscientist Rachel Wurzman.
Now Playing: Science for the People

#543 Give a Nerd a Gift
Yup, you guessed it... it's Science for the People's annual holiday episode that helps you figure out what sciency books and gifts to get that special nerd on your list. Or maybe you're looking to build up your reading list for the holiday break and a geeky Christmas sweater to wear to an upcoming party. Returning are pop-science power-readers John Dupuis and Joanne Manaster to dish on the best science books they read this past year. And Rachelle Saunders and Bethany Brookshire squee in delight over some truly delightful science-themed non-book objects for those whose bookshelves are already full. Since...
Now Playing: Radiolab

An Announcement from Radiolab